David Ternant

4.5k total citations
93 papers, 2.8k citations indexed

About

David Ternant is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Genetics. According to data from OpenAlex, David Ternant has authored 93 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Radiology, Nuclear Medicine and Imaging, 27 papers in Immunology and 24 papers in Genetics. Recurrent topics in David Ternant's work include Monoclonal and Polyclonal Antibodies Research (32 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Systemic Lupus Erythematosus Research (16 papers). David Ternant is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (32 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Systemic Lupus Erythematosus Research (16 papers). David Ternant collaborates with scholars based in France, United States and Belgium. David Ternant's co-authors include Gilles Paintaud, Denis Mulleman, Hervé Watier, Philippe Goupille, Charlotte Magdelaine–Beuzelin, Hervé Watier, Danielle Degenne, Émilie Ducourau, Théodora Bejan‐Angoulvant and Christophe Passot and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

David Ternant

91 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ternant France 29 1.0k 833 816 566 470 93 2.8k
David Mason United States 13 600 0.6× 909 1.1× 225 0.3× 769 1.4× 842 1.8× 19 2.7k
David Hagerty United States 19 1.6k 1.6× 284 0.3× 470 0.6× 709 1.3× 1.3k 2.8× 34 4.2k
Luís Teixeira France 28 585 0.6× 426 0.5× 336 0.4× 296 0.5× 255 0.5× 93 3.3k
Hye‐Soon Lee South Korea 31 1.0k 1.0× 342 0.4× 361 0.4× 249 0.4× 1.5k 3.1× 101 2.7k
Nicole Fabien France 35 894 0.9× 729 0.9× 220 0.3× 930 1.6× 764 1.6× 146 3.7k
Kenneth M. Kaufman United States 32 2.2k 2.2× 511 0.6× 524 0.6× 329 0.6× 1.8k 3.9× 87 4.0k
Anthony G. Wilson United Kingdom 24 712 0.7× 306 0.4× 188 0.2× 259 0.5× 807 1.7× 71 2.1k
Marcello Bagnasco Italy 35 1.3k 1.3× 458 0.5× 328 0.4× 336 0.6× 302 0.6× 164 4.2k
Melissa R. Snyder United States 25 749 0.7× 170 0.2× 1.0k 1.2× 240 0.4× 444 0.9× 66 3.0k
G. Dennis United States 22 1.9k 1.9× 308 0.4× 898 1.1× 289 0.5× 2.1k 4.4× 37 3.6k

Countries citing papers authored by David Ternant

Since Specialization
Citations

This map shows the geographic impact of David Ternant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ternant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ternant more than expected).

Fields of papers citing papers by David Ternant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ternant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ternant. The network helps show where David Ternant may publish in the future.

Co-authorship network of co-authors of David Ternant

This figure shows the co-authorship network connecting the top 25 collaborators of David Ternant. A scholar is included among the top collaborators of David Ternant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ternant. David Ternant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welzel, Tatjana, Andrew Atkinson, Verena Gotta, et al.. (2024). Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases. Pediatric Rheumatology. 22(1). 5–5. 3 indexed citations
2.
3.
Paintaud, Gilles, Nicolas Azzopardi, Christophe Passot, et al.. (2023). Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients. Clinical Pharmacokinetics. 62(9). 1263–1274. 1 indexed citations
4.
Desvignes, Céline, David Ternant, Thierry Lecomte, et al.. (2021). A Robust Enzyme-Linked Immunosorbent Assay to Measure Serum Ramucirumab Concentrations. Bioanalysis. 13(7). 565–574. 2 indexed citations
5.
Khoudour, Nihel, Dorothée Lebert, Fabienne Thomas, et al.. (2021). Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study. Pharmaceuticals. 14(8). 796–796. 19 indexed citations
6.
Petitcollin, Antoine, Nicolas Azzopardi, Jean‐Yves Pierga, et al.. (2021). Population pharmacokinetics and exposure–response relationship of trastuzumab and bevacizumab in early-stage breast cancer. European Journal of Clinical Pharmacology. 77(12). 1861–1873. 5 indexed citations
7.
Bagacean, Cristina, Adrian Tempescul, David Ternant, et al.. (2019). 17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia. Journal for ImmunoTherapy of Cancer. 7(1). 22–22. 12 indexed citations
8.
9.
Bensaid, R., David Ternant, Christophe Saint Etienne, et al.. (2019). TCT-685 Coronary Stenosis Before TAVR Are Not Necessarily Associated With Poorer 1-Year Prognosis and May Be Medically Managed. Journal of the American College of Cardiology. 74(13). B672–B672. 1 indexed citations
10.
Petitcollin, Antoine, Marie‐Clémence Verdier, Camille Tron, et al.. (2019). Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review. Clinical Pharmacokinetics. 59(1). 37–49. 32 indexed citations
11.
Lioger, Bertrand, F. Maillot, David Ternant, et al.. (2018). Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. The Journal of Pediatrics. 204. 225–233.e8. 8 indexed citations
12.
Paintaud, Gilles, Maud François, Béatrice Birmelé, et al.. (2017). Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis. ˜The œNephron journals/Nephron journals. 135(4). 261–267. 8 indexed citations
13.
Campone, Mario, Jean‐Louis Merlin, Valérie Gouilleux‐Gruart, et al.. (2015). Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non‐metastatic breast cancer. British Journal of Clinical Pharmacology. 81(5). 941–948. 25 indexed citations
14.
Maruani, A., et al.. (2015). Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review. Acta Dermato Venereologica. 95(4). 401–406. 5 indexed citations
15.
Ternant, David, Gilles Paintaud, Gilles Thibault, et al.. (2014). Encéphalite à anticorps anti-récepteurs N-méthyl-d-aspartate (NMDA-R) : place des immunomodulateurs. Archives de Pédiatrie. 21(6). 620–623. 3 indexed citations
16.
Ternant, David, Danielle Degenne, Nicolas Azzopardi, et al.. (2009). An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Cetuximab. Therapeutic Drug Monitoring. 31(5). 597–601. 53 indexed citations
17.
Paintaud, Gilles, et al.. (2009). Les anticorps monoclonaux : une avancée thérapeutique récente et majeure. Therapies. 64(1). 1–7. 4 indexed citations
18.
Ternant, David, Émilie Hénin, Guillaume Cartron, et al.. (2009). Development of a drug–disease simulation model for rituximab in follicular non‐Hodgkin's lymphoma. British Journal of Clinical Pharmacology. 68(4). 561–573. 16 indexed citations
19.
Ternant, David, Alexandre Aubourg, Charlotte Magdelaine–Beuzelin, et al.. (2008). Infliximab Pharmacokinetics in Inflammatory Bowel Disease Patients. Therapeutic Drug Monitoring. 30(4). 523–529. 151 indexed citations
20.
Ternant, David, Matthias Büchler, Maud Bénéton, et al.. (2007). Interindividual variability in the concentration–effect relationship of antilymphocyte globulins—a possible influence of FcγRIIIa genetic polymorphism. British Journal of Clinical Pharmacology. 65(1). 60–68. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Mason Breakdown of academic impact, for papers by David Hagerty Breakdown of academic impact, for papers by Luís Teixeira Breakdown of academic impact, for papers by Hye‐Soon Lee Breakdown of academic impact, for papers by Nicole Fabien Breakdown of academic impact, for papers by Kenneth M. Kaufman Breakdown of academic impact, for papers by Anthony G. Wilson Breakdown of academic impact, for papers by Marcello Bagnasco Breakdown of academic impact, for papers by Melissa R. Snyder Breakdown of academic impact, for papers by G. Dennis
Rankless by CCL
2026